Taiwan FDA registration c9f89a0973bfa493c26a9fa2138ea114
"Seawon" Lymphocyte separation medium (NON-Sterile)
TW: "膝望" 淋巴球分離培養基 (未滅菌)
Taiwan·Risk Class 1·MD·SEAWON MEDITECH CO., LTD.·Registered Jun 17, 2016 – Jun 17, 2021ExpiredRegistration details
- Analysis ID
- c9f89a0973bfa493c26a9fa2138ea114
- License Form
- Ministry of Health Medical Device Import No. 016661
- Customs Code
- DHA09401666101
Company information
- Manufacturer
- SEAWON MEDITECH CO., LTD.
- Manufacturer Country
- Korea, Republic of
- Authorized Representative
- GREAT RIVER LIFECARE INC.
Product details
- Intended Use
- Limited to the first level identification range of the Measures for the Administration of Medical Devices "Lymphocyte Separation Medium (B.8500)".
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B8500 Lymphocyte Isolation Medium
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jun 17, 2016
- Expiry Date
- Jun 17, 2021
About this record
Access comprehensive regulatory information for "Seawon" Lymphocyte separation medium (NON-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number c9f89a0973bfa493c26a9fa2138ea114 and manufactured by SEAWON MEDITECH CO., LTD.. The authorized representative in Taiwan is GREAT RIVER LIFECARE INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices